In the news release, IEI Secures TFDA QMS Approval and ISO 13485 Certification, Reinforcing Audit-Ready Manufacturing for MedTech Design Transfers, issued 21-Nov-2025 by IEI Integration Corp. over PR Newswire, we are advised by the company that in the sentence “For more MedTech information, visit the IEI Medical Portal.” there is a missing link. The complete, corrected release follows:

IEI Secures TFDA QMS Approval and ISO 13485 Certification, Reinforcing Audit-Ready Manufacturing for MedTech Design Transfers

Dual certifications streamline global design transfers and regulatory compliance.

TAIPEI, Nov. 24, 2025 /PRNewswire/ — IEI Integration Corp. (“IEI”), a global provider of medical and industrial computing platforms, today announced that its New Taipei City (Xizhi) and Qidu (Keelung) facilities have passed inspection by the Taiwan Food and Drug Administration (TFDA) and been awarded Quality Management System (QMS) approval (Xizhi Certificate No. QMS2376、Keelung Certificate No. QMS2377), while maintaining ISO 13485:2016 certification. As one of Taiwan’s manufacturers holding both domestic and international medical QMS credentials, IEI enables OEM/ODM/CDMO clients to accelerate regulatory readiness and scale production across Asia, the United States, and Europe. 

Backed by TFDA Class II credentials, IEI is prioritizing CDMO partnerships in medical imaging peripherals, vital-sign monitoring, and endoscopy/OR integration—bringing compliant designs to clinical use faster.

IEI’s Qidu (Chi-Du) campus delivers 38K PCBA units per month and 38K system units per month, supporting rapid ramps and regional fulfillment. Additional capacity in Taoyuan is under planning, with a phased build-out to support forecast demand and regionalized logistics

“Layering TFDA approval on top of ISO 13485 enables smoother, more predictable audits, faster design transfers, and more reliable scale-up in regulated markets.” said Kenny Jan, Senior Vice President of IEI’s Medical Business Unit.

For a Europe-based Class II endoscopic device program, IEI applied a highly automated smart-factory toolset—pick-to-light material handling, X-ray component counting, and automatic visual identification—to stabilize ramp. MES-linked traceability, AXI/vision inspection, and documented CAPA evidence further supported audit readiness.

Operating under its unified governance model—the IEI “Trust Stack”—IEI runs an ISO 13485/TFDA-compliant smart factory that spans ISO/IEC 27001 (information security), ISO 28000 (supply-chain security), IECQ QC 080000 (hazardous-substance process governance), and organization-level ISO 14064-1 GHG accounting. This framework reduces validation time, simplifies audits, and ensures end-to-end transparency for MedTech brands.

By aligning domestic TFDA compliance with global ISO frameworks, IEI provides medical customers with a transparent, audit-ready manufacturing base built for multi-market expansion.

About IEI Integration Corp.

Founded in 1997, IEI Integration Corp. is a global provider of medical and industrial computing platforms and CDMO/ODM services. IEI enables regulated MedTech and edge-AI applications through design-to-manufacturing expertise, delivering advanced medical computers, network appliances, and embedded platforms supported by robust quality, regulatory, and cybersecurity frameworks.

For more MedTech information, visit the IEI Medical Portal.
Learn more about IEI at www.ieiworld.com/en.

BEIJING, Nov. 24, 2025 /PRNewswire/ — After the New York leg in March 2024, the “Blanc de Chine • Porcelain from Dehua” international itinerant exhibition opened in the United States again on November 20.

Organized by southeast China county Dehua, the exhibition saw 100-plus exquisite porcelain exhibits transported from Quanzhou City, a famous node of the Maritime Silk Road, to Los Angeles to meet with American ceramic lovers.

While marveling at the prowess and superb beauty of Dehua porcelains, Fred Stehle, a U.S. visitor, said he expected there would be more chances to appreciate the Chinese porcelain art and feel the unique beauty of Chinese culture in the future.

Dehua, where porcelain-making could be dated back to around 3,700 years ago, has borne witness to formation of the local ceramic industry as early as in late Tang Dynasty, making it a hallmark of the Chinese ceramics.

Since Song Dynasty, flourishing trade along the Maritime Silk Road has helped Dehua export local porcelains, known for their jade-like texture and skillful sculpture technique, to East Asia, Southeast Asia, Northeast Africa, the Middle East, Europe and the Americas.

Nowadays, Dehua County has become one of the largest ceramic artware production and export bases in China, with its ceramic products sold to more than 190 countries and regions around the world.

Denise Menchaca, mayor of San Gabriel, said that white porcelains of Dehua had been brought historically to different places along the Maritime Silk Road, linking the oriental philosophy, tradition and stories with the western ones.

Today, Dehua white porcelain, as a symbol of harmony, has become a bridge for closer friendship and communications as well, noted Menchaca.

During a promotion event held on November 21, Fang Junqin, Party Chief of Dehua County, said Dehua would leverage the Los Angeles exhibition to expand win-win cooperation with U.S. peers in ceramic design innovation, brand co-building and industrial collaboration.

On November 21, representatives of Dehua inked MoUs for strategic cooperation with China General Chamber of Commerce – Los Angeles and Thunder International Group to help Dehua optimize cross-border supply chains and explore overseas markets.

Via joining hands with partners of different sectors, Dehua is dedicated to widening its international “circle of friends” to make “Blanc de Chine”, the shared beauty of different cultures, a carrier of people-to-people bond, added Fang.

Original link: https://en.imsilkroad.com/p/348439.html  

DOVER, Del., Nov. 24, 2025 /PRNewswire/ — Paperpal, the AI writing and research assistant by Cactus Communications (CACTUS), surpasses three million users worldwide, marking a major milestone in its mission to empower students and researchers to write with clarity, precision, and integrity.

Paperpal’s rapid growth reflects its strong adoption in the academic community amid the rising need for reliable AI tools. The platform has tripled its user base in the past 18 months driven by its commitment to ethical AI that brings out the best in every user. With its deep understanding of academic writing, it has a proven ability to help users communicate research with confidence, while preserving their authentic voice.

Akhilesh Ayer, CEO, Cactus Communications, said, “As academia embraces AI, the focus remains on solutions that amplify human expertise. Crossing the three-million-user mark is more than a milestone for Paperpal; it is a testament to the growing trust in our vision to empower every academic with ethical, high-impact AI that advances scholarly communication.”

Nishchay Shah, Group CTO and EVP, Products & AI, Cactus Communications, added, “Researchers want more than generic AI; they seek intelligent, reliable partners that understand their academic journey. That’s what we offer. From polishing manuscripts and checking submission readiness to helping researchers find their scientific voice, Paperpal brings everything together in one intuitive platform. This milestone is not just about scale but about earning the trust of academics who see Paperpal as essential to their research journey.”

Paperpal encourages responsible authorship, supporting academics at every stage of research and writing. Its technology powers submission workflows for leading publishers, ensuring consistent quality, integrity, and efficiency. Students also rely on Paperpal to strengthen writing skills, improve clarity, and gain confidence in coursework and theses. With grammar checking, paraphrasing, plagiarism detection, AI summarization, and more, Paperpal helps users save time and focus on their research.

Academics consistently highlight Paperpal’s ease of use, comprehensive features, and accurate discipline-aware suggestions as top reasons for using the platform. Many say it helps them “think and write confidently without compromising quality” and “refine writing and grammar without losing their unique style.”

Paperpal has earned the trust of students, researchers, and institutions worldwide. It continues to grow as a platform that helps academics improve writing quality, communicate their science clearly, and overcome barriers to publication success.

For more details, please contact: Nidhi Amin
Cactus Communications
nidhi.amin@cactusglobal.com
newsroom@cactusglobal.com

KUALA LUMPUR, Malaysia, Nov. 24, 2025 /PRNewswire/ — DirectD, one of Malaysia’s largest multi-brand smartphone retailers, today announced a strategic partnership with JCL Credit Leasing (JCL), a Tokyo-headquartered financial services group, to expand accessibility to quality smartphones nationwide. The collaboration is set to remove key barriers to device ownership and simultaneously embed circular-economy principles to reduce e-waste and lifecycle carbon emissions.

By offering high-quality, reliable devices through accessible options, including flexible financing for owning, subscribing, or upgrading, the partnership aims to boost productivity across work and study for Malaysians from all segments of society, enhancing their daily lives.

“We’re excited to work with JCL to broaden access to reliable smartphones – an essential tool that powers income, learning, business transaction, and daily life,” said Amy Tan, CEO of DirectD. “Combining affordability with an easy upgrade or trade-in path keeps devices working longer, hence reducing our Scope 3 emissions and advancing our ESG agenda.”

“Digital inclusion and sustainability go hand in hand,” commented Mr. Yutaka Tanimoto, Director of JCL. “By pairing JCL’s consumer-finance expertise with DirectD’s nationwide footprint, we aim to help more Malaysians participate in the digital economy on transparent and manageable terms, supporting both individual productivity and environmental responsibility.”

Customers can look forward to lower financial hurdles and new ways to obtain higher quality devices across Malaysia, with special attention paid to underserved communities. To stretch budgets further, customers may trade in eligible devices for value toward their next phone. With circularity initiative, devices are routed to certified third-party partners for testing and refurbishment, then redeployed to extend lifecycles. Meanwhile, non-recoverable units are responsibly recycled to reduce e-waste and estimated lifecycle emissions.

DirectD has served more than one million consumers over the years and aims to deliver 30,000 devices to underserved communities through the partnership with JCL in 2026.

About DirectD

DirectD is a leading multi-brand smartphone retailer in Malaysia, offering nationwide retail coverage, trade-in, and upgrade services. DirectD champions reliable, high-quality devices through affordability programs that maximize customer value. Learn more at https://pakaidulu.directd.com.my. DirectD has a total of more than 20 stores nationwide. For locations and full listings, visit https://www.directd.com.my/shop-location

About JCL

JCL is a Tokyo-headquartered financial services group specializing in inclusive, and transparent that expand access to financial products and services across Asia.  Learn more at https://jcl.my/

Collaborates with Visa to offer ‘Jubilant Red Christmas Spending Rewards’ with Cash Rebates and Lucky Draw Entries

• To mark its 20th anniversary, Link is launching a “Jubilant Red Christmas” campaign across 20 of its malls, featuring red-themed décor and optical illusion art installations, candy-themed photo spots and festive Jelly Belly scenes. 
• Link is partnering with Visa for the first time to offer “Jubilant Red Christmas Spending Rewards”. Shoppers with spending of $2,800 or more can enjoy a 4.5% cash rebate and enter a lucky draw to win nearly $100,000 worth of cash vouchers.

HONG KONG, Nov. 24, 2025 /PRNewswire/ — Link Asset Management (Link) is collaborating with the classic American candy brand Jelly Belly to present the “Jubilant Red Christmas” campaign from 21 November 2025 to 11 January 2026, making this a sweet Christmas celebration filled with love and joy. In addition, to mark Link’s 20th anniversary this year, 20 Link malls have been decorated in dazzling red and feature optical illusion art installations to create a series of creative and playful photo spots and Christmas scenes featuring Mr Jelly Belly, the candy company’s official mascot.

Dazzling Red Photo Spots & Candy Elf Jumping Contest

During the event, 20 Link malls will turn into playful candy factories, themed in stunning red.

Mr Jelly Belly will surprise shoppers at various optical illusion art scenes. Lok Fu Plaza features a giant candy hot air balloon and a “Bean” train, Kai Tin Shopping Centre has a “Bean” racetrack and a giant capsule machine, and TKO Gateway is filled with romantic pink candies, creating a sweet atmosphere.

Kai Tin Shopping Centre will host a “Candy Elf Jumping Contest” on 3 January 2026, inviting kids to  dress as candy elves for the competition. Participation is free, and participants will receive generous gift packs. Winners will have a chance to win exclusive Jelly Belly boxsets and other prizes. The event will also feature exciting performances, and free candy will be distributed on-site, bringing the festive atmosphere to a climax.

“Jubilant Red Christmas Spending Rewards” with Cash Rebates of up to 4.5% & Lucky Draw Entries

This Christmas, Link is partnering with Visa to launch the “Jubilant Red Christmas Spending Rewards”.  During the promotion, customers with cumulative spending of $2,800 or more using Visa credit cards at participating tenants of the 20 Link malls will receive a $130 cash rebate. Eligible transactions also come with a lucky draw entry for a chance to win nearly $100,000 in mall cash vouchers. There are also numerous shopping discounts and offers for Visa cardholders – don’t miss out on these great deals!

“Jubilant Red Christmas Campaign“
Promotion Period: 21 November 2025 to 11 January 2026
Locations: 20 participating Link malls^

Link x Visa “Jubilant Red Christmas Spending Reward” 
Promotion Period: 21 November 2025 to 11 January 2026 Description: During the promotion period, customers with cumulative spending of $2,800 or more using registered Visa credit cards at participating tenants across all 20 participating Link malls will receive a cash rebate of up to $130 (available in limited quantities on a first-come, first-served basis while stock lasts). Each eligible Visa card transaction comes with one lucky draw entry.
Locations: 20 participating Link malls^
*Visa cardholders must register their cards to be eligible for this event
*Each cardholder may register multiple Visa cards for the event; each registered Visa credit card is eligible for the rebate reward twice during the event period 
*A minimum of $60 applies for each eligible card payment transaction
*Each registered Visa card can enjoy up to five lucky draw entries
Registration website: http://visaselectrewardhk.com/Link 

^20 participating Link malls include: T Town, Tin Shing Shopping Centre, Tin Chak Shopping Centre, Tin Yiu Plaza, Butterfly Plaza, Leung King Plaza, Choi Yuen Plaza, Tai Wo Plaza, Wo Che Plaza, Lok Fu Place, Temple Mall, Kai Tin Shopping Centre, Sau Mau Ping Shopping Centre, Lei Yue Mun Plaza, TKO Gateway, TKO Spot, Homantin Plaza, Tsz Wan Shan Shopping Centre, Fu Tung Plaza and Yat Tung Shopping Centre

Candy Elf Jumping Contest
Venue:  Event Area, 2/F, Kai Tin Shopping Centre, Lam Tin
Date: Saturday, 3 January 2026
Time: 2–4pm
Terms and conditions apply. Programme contents are subject to change without notice.
Event details: https://www.linkhk.com

Download images:
https://drive.google.com/drive/folders/1P-CH0SCOSH1CteX4s5J1C0EpDOWGzKaW?usp=sharing

–ENDS–

About Link Asset Management Limited

Link Asset Management Limited (Link) is a leading, independent, and fully integrated real estate investor and manager focusing on the APAC region. It manages Link Real Estate Investment Trust (Link REIT, Hong Kong stock code: 823), one of the largest REITs in Asia, and its real estate investment portfolio. Link also aims to leverage its investment management capabilities to serve as a trusted investment manager to capital partners through its business line, Link Real Estate Partners.

Building on its strong track record over almost two decades, Link targets to deliver resilient returns and growth to its unitholders. Link offers a “REIT plus” investment case through its strategic focus on diversifying the Link REIT Portfolio across geographies and asset classes in APAC and expanding its investment management business.

Link aspires to be the trusted partner in APAC real estate sector for unitholders, capital partners, tenants, and the wider communities it serves.

For more information about Link, please visit www.laml.com/en/. 

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Nov. 24, 2025 /PRNewswire/ — Harbour BioMed (“HBM” or the “Company”; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics for immunology and oncology, today announced an update and advancement of its global strategic collaboration with AstraZeneca, originally established in March 2025. The collaboration aims to discover and develop next-generation biotherapeutics, including antibody-drug conjugates (ADCs) and T cell engagers, leveraging the knowledge of both companies.

Under the terms of the agreement, AstraZeneca will continue to nominate discovery programs to Harbour BioMed each year over the next four years, reflecting the continued progress of the partnership, and will retain the option to license these programs for further development. Harbour BioMed will be eligible to receive option and option exercise fees, development and commercial milestone payments, plus tiered royalties on future net sales on such licensed programs. The economic terms are consistent with the financial framework established in March 2025.

Dr. Jingsong Wang, Founder, Chairman and CEO of Harbour BioMed, said: “We are pleased to advance our collaboration with AstraZeneca to develop next-generation biotherapeutics in oncology. Harbour BioMed has collaborated with AstraZeneca on multiple programs since 2022, and over time, the two parties have established a trusted and solid partnership. With our strong capabilities enabled by our proprietary antibody platforms, we are well positioned to support AstraZeneca in developing innovative biotherapeutics that can address significant unmet medical needs and improve patient outcomes globally.”

About Harbour BioMed

Harbour BioMed (HKEX: 02142) is a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology. The company is building a robust and differentiated pipeline through internal R&D capabilities, strategic global collaborations in co-discovery and co-development, and selective acquisitions.

Harbour BioMed’s proprietary antibody technology platform, Harbour Mice^®, generates fully human monoclonal antibodies in both the conventional two heavy and two light chain (H2L2) format and the heavy chain-only (HCAb) format. Building upon HCAb antibodies, the HCAb-based immune cell engagers (HBICE^®) bispecific antibody technology enables tumor-killing effects that traditional combination therapies cannot achieve. Additionally, the HCAb-based bispecific immune cell antagonist (HBICA^TM) technology empowers the development of innovative biologics for immunological and inflammatory diseases. By integrating Harbour Mice^®, HBICE^®, and HBICA^TM with a single B-cell cloning platform, Harbour BioMed has built a highly efficient and distinctive antibody discovery engine for developing next-generation therapeutic antibodies. For more information, please visit www.harbourbiomed.com.